SEC Form 4 · accession 0001645627-18-000006
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jan 28, 2018
Accepted (ET)
Feb 2, 2018 · 2:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 29, 2018 | P | 2,000 | $0.0158 | A | 24,763,189 | D | |
| Common Stock | Jan 26, 2018 | P | 2,000 | $0.052 | A | 24,765,189 | D | |
| Common Stock | Jan 29, 2018 | P | 1,000 | $0.0517 | A | 24,766,189 | D | |
| Common Stock | Jan 29, 2018 | P | 2,000 | $0.0515 | A | 24,768,189 | D | |
| Common Stock | Jan 29, 2018 | P | 2,000 | $0.0513 | A | 24,770,189 | D | |
| common Stock | Jan 29, 2018 | P | 1,000 | $0.0517 | A | 24,771,189 | D | |
| Common Stock | Jan 30, 2018 | P | 2,000 | $0.053 | A | 24,773,189 | D | |
| Common Stock | Jan 30, 2018 | P | 1,000 | $0.053 | A | 24,774,189 | D | |
| Common Stock | Jan 30, 2018 | P | 1,000 | $0.052 | A | 24,775,189 | D | |
| Common Stock | Jan 30, 2018 | P | 2,000 | $0.052 | A | 24,778,189 | D | |
| common Stock | Jan 30, 2018 | P | 1,000 | $0.05 | A | 24,779,189 | D |
Table II — derivative securities
No Table II lines on this filing.